Diferencia entre revisiones de «EBQ:MATTERs Study»
Sin resumen de edición |
Sin resumen de edición |
||
| Línea 55: | Línea 55: | ||
==Funding== | ==Funding== | ||
==Further Reading== | |||
[[EBQ:CRASH-2_Trial]] | |||
==Sources== | ==Sources== | ||
<references/> | <references/> | ||
[[Category:EBQ]] | [[Category:EBQ]] | ||
Revisión del 16:48 10 mar 2014
Under Review Journal Club Article
Morrison J. et al. "Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study". JAMA Surgery. 2012. 147(2):113-119.
PubMed Full text PDF
PubMed Full text PDF
Clinical Question
Does administration of Tranexamic (TXA) acid in trauma patients with hemorrhage improve mortality in a wartime setting?
Conclusion
The use of TXA with blood component-based resuscitation following combat injury results in improved measures of coagulopathy and survival, a benefit that is most prominent in patients requiring massive transfusion